POPA Recon받) 현재 난리났다는 암 백신 근황
받) 현재 난리났다는 암 백신 근황 1. Past cancer vaccines used common antigens for all patients, failing to overcome individual differences and failing in phase 3. 2. Moderna analyzed the genes of the patient's tumor and created an mRNA vaccine with personalized mutations, proving the success of Phase 3. 3. mRNA technology, which was used as a virus vaccine such as Corona, has been upgraded to an anticancer drug platform by preventing recurrence and distant metastasis in cancer patients. 4. In melanoma adjuvant therapy clinical trials, the combination of ‘Keytruda + personal mRNA’ proved to be more effe…
The excerpt is quoted from a public Telegram channel, which owns its text.